Investors
Oxurion/Investors/News

Investor news.

Regulated information, press releases and inside information published by Oxurion. Documents are available as PDF in English, Dutch and French.

456 press releases
18 Jun 2026
Regulated

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

ENNL
15 Jun 2026

Major market validation: Pierre Fabre Laboratories use Oxurion's Exagis platform

ENFRNL
10 Jun 2026
Regulated

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

ENNL
8 Jun 2026

Oxurion launches a software-driven growth strategy with Exagis

ENFR
3 Jun 2026
Regulated

Oxurion – Results of the Annual Shareholders Meeting of June 1, 2026

ENNL
2 Jun 2026
General

Oxurion expands its capabilities to address the growing demand for GLP-1 and peptide clinical research services

ENNLFR
2 Jun 2026
Regulated

Oxurion – Termination of discussions for the French CRO project (LOI dated 13/10/25) and prioritization of the international target (LOI dated 19/03/26)

ENNLFR
29 May 2026
Regulated

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC

ENNL
27 May 2026
RegulatedTransparency/Denominator

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas

ENNL
26 May 2026
Regulated

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

ENNL
18 May 2026
Events

2026-06-01 – 2026 Annual Shareholders Meeting

Read
18 May 2026
Events

2026-09-30 – Publication of the Half-year Report

…